Anvilab Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Anvilab General Information


Manufacturer of generic pharmaceutical products. The company owns the rights to sell Antigrippin-Maximum, Gepagard, and Inflyunet, pharmaceutical brands and owns the trademark Laborotoria ANVI. It develops life saving drugs for chemotherapy, antiviral and others.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • Kashirskoye Sh. 22, Building 4
  • Moscow
  • Russia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anvilab Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anvilab‘s full profile, request access.

Request a free trial